| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Processa Pharmaceuticals, Inc. (PCSA) has 10 insiders with recent SEC Form 4 filings, including 7 buys and 8 sells. PCSA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 300.0K | $780.0K | - | |
| ? | 300.0K | $780.0K | - | |
| CEO | 256.0K | $665.6K | - | |
| Other | 111.0K | $288.6K | - | |
| CFO | 108.0K | $280.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23, 2021 | Young David | Chief Executive Officer | Buy | 10,000 | $7.67 | $76,716.00 | +3.0% | -4.1% | -61.8% | |
| Jun 22, 2021 | Floyd Robert Michael | Chief Operating Officer | Buy | 2,000 | $7.03 | $14,058.40 | +7.7% | +1.4% | -60.2% | |
| Jun 21, 2021 | Lin Patrick | Chief Business - Strategy Off | Buy | 2,000 | $6.65 | $13,300.00 | +0.5% | +4.7% | -59.5% | |
| Jun 21, 2021 | Stanker James H | Chief Financial Officer | Buy | 1,000 | $6.81 | $6,810.00 | +2.8% | +4.7% | -59.5% | |
| Apr 14, 2021 | Yorke Justin W56 | Director | Sell | 16,200 | $9.60 | $155,464.00 | -3.1% | -21.3% | -65.9% | |
| Apr 8, 2021 | Besser James E76 | See Remarks | Sell | 447,771 | $10.77 | $4,821,341.61 | -14.0% | -21.9% | -66.7% | |
| Feb 22, 2021 | Besser James E76 | 10% Owner | Sell | 28,929 | $11.49 | $332,289.24 | -0.9% | - | - | |
| Oct 2, 2020 | Besser James E76 | 10% Owner | Buy | 30,000 | $4.04 | $121,200.00 | +8.0% | - | - | |
| Oct 1, 2020 | Stanker James H | Chief Financial Officer | Buy | 6,000 | $2.10 | $12,600.00 | +14.5% | - | - | |
| Oct 1, 2020 | Lin Patrick | Chief Business - Strategy Off | Buy | 31,250 | $2.10 | $65,625.00 | +8.5% | - | - |